Commissioner of commerce and commissioner of health access permission to certain data collected
SF4095 expands access to Minnesota’s all-payer claims data and related health insurance data for specified public purposes. The bill amends existing law to allow the commissioner of commerce, subject to existing data-use limits, to access certain private or nonpublic claims data to carry out health insurance oversight duties, and it authorizes access for researchers and organizations working on health care outcomes, access, quality, disparities, or spending when the use serves a public benefit.
The bill also directs the commissioner to build a more formal data-access framework, including application procedures, legally enforceable data-use agreements, oversight and compliance safeguards, technical assistance, and a fee schedule that supports access without creating barriers for users most affected by disparities. In addition, it requires the creation of a research advisory group to review data-use applications and adds a new requirement that the commissioner provide certain data collected under chapter 62W to the commissioner of health.
The bill would amend Minnesota Statutes sections 62U.04 and 62W.06 to broaden interagency and research access to health-related data while preserving privacy and market-protection limits. It affects the handling of all-payer claims data, health insurance oversight, and state agency data-sharing practices, and it would require the commerce commissioner to establish new administrative processes, safeguards, and advisory review mechanisms for data access and use.
Based on the bill text and the absence of recorded committee testimony or votes, the measure appears to be framed as a data-access and public-interest transparency bill rather than a controversial policy overhaul. Its stated goals emphasize research, oversight, disparities, and public benefit, suggesting generally supportive intent around improving health system analysis and government coordination.
The main points of tension are likely to center on privacy, data security, and competitive concerns. The bill explicitly prohibits reidentification, unfair market advantage, and public reporting of certain contract details, which indicates sensitivity to provider, payer, and health plan concerns about misuse of claims data. It also tries to balance access with safeguards and fees that do not deter users affected by disparities, suggesting possible debate over how open the data should be, who should be allowed access, and how much administrative control the commissioner should retain.